Cargando…

GYY4137 and Sodium Hydrogen Sulfide Relaxations Are Inhibited by L-Cysteine and K(V)7 Channel Blockers in Rat Small Mesenteric Arteries

Donors of H(2)S may be beneficial in treating cardiovascular diseases where the plasma levels of H(2)S are decreased. Therefore, we investigated the mechanisms involved in relaxation of small arteries induced by GYY4137 [(4-methoxyphenyl)-morpholin-4-yl-sulfanylidene-sulfido-λ5-phosphane;morpholin-4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abramavicius, Silvijus, Petersen, Asbjørn G., Renaltan, Nirthika S., Prat-Duran, Judit, Torregrossa, Roberta, Stankevicius, Edgaras, Whiteman, Matthew, Simonsen, Ulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032876/ https://www.ncbi.nlm.nih.gov/pubmed/33841145 http://dx.doi.org/10.3389/fphar.2021.613989

Ejemplares similares

Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis
por: Meng, Guoliang, et al.
Publicado: (2015)

Synthesis of Sulfur-35-Labeled Trisulfides and GYY-4137 as Donors of Radioactive Hydrogen Sulfide
por: Brown, Eric M., et al.
Publicado: (2023)

Hydrogen Sulfide Donor GYY4137 Rescues NRF2 Activation in Respiratory Syncytial Virus Infection
por: de Mello, Aline Haas, et al.
Publicado: (2022)

The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells
por: Li, Ling, et al.
Publicado: (2013)

The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo
por: Lee, Zheng Wei, et al.
Publicado: (2011)

Improved growth of pea, lettuce, and radish plants using the slow release of hydrogen sulfide from GYY-4137
por: Carter, Justin M., et al.
Publicado: (2018)

GYY4137-Derived Hydrogen Sulfide Donates Electrons to the Mitochondrial Electron Transport Chain via Sulfide: Quinone Oxidoreductase in Endothelial Cells
por: Star, Bastiaan S., et al.
Publicado: (2023)

GYY4137, a Hydrogen Sulfide Donor Modulates miR194-Dependent Collagen Realignment in Diabetic Kidney
por: John, AM Sashi Papu, et al.
Publicado: (2017)

Experimental research into the potential therapeutic effect of GYY4137 on Ovariectomy-induced osteoporosis
por: Xu, Zhong-Shi, et al.
Publicado: (2018)

Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H(2)S-Producing Enzymes in Multiple Sclerosis
por: Lazarević, Milica, et al.
Publicado: (2020)

The protective effects of GYY4137 on ipsilateral testicular injury in experimentally varicocele-induced rats
por: Ning, Jin-Zhuo, et al.
Publicado: (2018)

A H(2)S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice
por: Liu, Mi, et al.
Publicado: (2016)

The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain
por: Bai, Xue, et al.
Publicado: (2021)

Local Vibrational Therapy for Essential Tremor Reduction: A Clinical Study
por: Abramavičius, Silvijus, et al.
Publicado: (2020)

GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo
por: Chen, Zeyang, et al.
Publicado: (2019)

Vasoactive Effects of Chronic Treatment with Fructose and Slow-Releasing H(2)S Donor GYY-4137 in Spontaneously Hypertensive Rats: The Role of Nitroso and Sulfide Signalization
por: Berenyiova, Andrea, et al.
Publicado: (2022)

GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats
por: Meng, Guoliang, et al.
Publicado: (2015)

GYY4137 Promotes Mice Feeding Behavior via Arcuate Nucleus Sulfur-Sulfhydrylation and AMPK Activation
por: Zhou, Jun, et al.
Publicado: (2018)

GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling
por: Juin, Subir Kumar, et al.
Publicado: (2021)

A case report and literature review: previously excluded tuberculosis masked by amiodarone induced lung injury
por: Karinauske, Egle, et al.
Publicado: (2018)

Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death
por: Sakuma, Satoru, et al.
Publicado: (2019)

TRPA1 Ion Channel Determines Beneficial and Detrimental Effects of GYY4137 in Murine Serum-Transfer Arthritis
por: Bátai, István Z., et al.
Publicado: (2019)

Increased circulating peroxiredoxin-4 in sepsis model rats involves secretion from hepatocytes and is mitigated by GYY4137
por: Unuma, Kana, et al.
Publicado: (2019)

Novel approach towards antimicrobial chemotherapy optimization in lower respiratory tract infections in children: An observational study
por: Abramavicius, Silvijus, et al.
Publicado: (2021)

A New Slow Releasing, H(2)S Generating Compound, GYY4137 Relaxes Spontaneous and Oxytocin-Stimulated Contractions of Human and Rat Pregnant Myometrium
por: Robinson, Hayley, et al.
Publicado: (2012)

A retrospective analysis of treatment outcomes of drug-susceptible TB in Kazakhstan, 2013–2016
por: Sadykova, Laura, et al.
Publicado: (2019)

GYY4137, an H(2)S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson’s Disease
por: Hou, Xiaoou, et al.
Publicado: (2017)

The H(2)S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
por: Lazarević, Milica, et al.
Publicado: (2018)

The H(2)S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H(2)S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus
por: Van Dingenen, Jonas, et al.
Publicado: (2019)

GYY4137 a H(2)S donor, attenuates ipsilateral epididymis injury in experimentally varicocele-induced rats via activation of the PI3K/Akt pathway
por: Xia, Yu-qi, et al.
Publicado: (2019)

Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report
por: Abramavicius, Silvijus, et al.
Publicado: (2017)

Cisplatin-induced sudden cardiac death with hemodynamic collapse: a severe adverse drug reaction: Case report
por: Abramavicius, Silvijus, et al.
Publicado: (2017)

Non-endothelial endothelin counteracts hypoxic vasodilation in porcine large coronary arteries
por: Hedegaard, Elise R, et al.
Publicado: (2011)

Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors HNRNPD and SRSF2
por: Latorre, Eva, et al.
Publicado: (2018)

The Glomerular Filtration Rate Estimators in the Pharmacokinetic Modelling in Acute Kidney Injury: An Observational Study
por: Abramavicius, Silvijus, et al.
Publicado: (2021)

Blood biomarkers in early bacterial infection and sepsis diagnostics in feverish young children
por: Dagys, Algirdas, et al.
Publicado: (2022)

4137 Discrimination, Social Cohesion, and Hypertension: A Cross-Sectional Analysis from the REGARDS Study
por: McCann, Zachary H, et al.
Publicado: (2020)

Hydrogen Sulfide Is a Novel Protector of the Retinal Glycocalyx and Endothelial Permeability Barrier
por: Allen, Claire L., et al.
Publicado: (2021)

The mitochondria-targeted sulfide delivery molecule attenuates drugs-induced gastropathy. Involvement of heme oxygenase pathway.
por: Magierowska, Katarzyna, et al.
Publicado: (2023)

The novel mitochondria-targeted hydrogen sulfide (H(2)S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro
por: Gerő, Domokos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n9sb4unapvoa3rhd0do2b5nhct